BESPOKE EXTRACTS, INC.

BSPK ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Revenue
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development
SG&A Expense $6.3M $34.5K $30.6K $92.2K $317.8K $391.6K $224.1K
Operating Income $-6.6M $-364.6K $-731.2K $-393.0K $-321.6K $-391.7K $-224.1K
Operating Margin
Interest Expense $63.3K $365 $1.0K
Pretax Income $-6.7M $-365.0K $-731.2K $-394.0K $-321.6K $-391.7K $-224.1K
Income Tax Expense
Net Income $-6.7M $-365.0K $-731.2K $-394.0K $-321.6K $-391.7K $-224.1K
Net Margin
EPS (Basic) $-0.48 $-0.13 $-0.30 $-0.25 $-0.09 $0.00 $0.00
EPS (Diluted) $-0.48 $-0.13 $-0.30 $-0.25 $-0.09 $0.00 $0.00
Shares Outstanding (Basic) 31.5M 2.9M 2.9M 7.3M 352.7M 327.7M 344.4M
Shares Outstanding (Diluted) 31.5M 2.9M 2.9M 7.3M 352.7M 327.7M 344.4M
Dividends Per Share
← Newer Page 2 of 2 Older →